Sanofi Shares Dip Below Key Technical Threshold at Midday, Down 23% Year-on-Year
Sanofi shares fell by 1.52% at midday this Tuesday, March 3, trading at 80.21 euros compared to 81.45 euros at the previous close. This decline is part of a broader downturn in European stock markets, impacted by geopolitical tensions in the Middle East. Over the year, the stock has now decreased by 23.14%.
Technical Indicators Highlight Bearish Trends
By settling at 80.21 euros, Sanofi has fallen below its 20-day moving average of 80.24 euros and remains significantly under its 200-day moving average, which stands at 83.68 euros. This negative gap of about three euros from the 200-day moving average indicates a medium-term bearish trend still in place. The RSI, at 47, remains in the neutral zone but leans towards weakening bullish momentum, consistent with the stock's trajectory over several months. The nearest support zone is around 77.08 euros, a threshold that could be tested if selling pressure continues. Over three months, the stock has lost 6.9%, confirming the difficulty of the stock to rebound sustainably despite some attempts observed at the beginning of the year.
Fundamental Outlook and Upcoming Financial Milestone
On the fundamental front, the next major milestone for Sanofi is set for April 23, 2026, the date for the publication of the first quarter results. This event will be closely watched to assess the pharmaceutical group's ability to stabilize its revenue trajectory and confirm its annual targets, in a macroeconomic environment made more complex by the surge in energy costs in Europe. The day's decline is part of a broader pullback in European markets, which fell between 1% and 3% this Tuesday in reaction to military operations in Iran and their consequences on global energy supplies. Although the healthcare sector is traditionally considered defensive, it has not been immune to the overall decline observed across all indices. The very low beta of the stock (0.02) usually illustrates a low correlation with major indices, but today's session shows that even the least cyclical stocks are subject to the pressures of a deteriorated geopolitical environment.
